Nelarabine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
25021-259 -
Package NDC
25021-259-50 -
Package NDC
25021-259-51 -
Application number
ANDA212605 -
SPL ID
c956537f-71c0-44bc-a2e2-ab2adaa4f756 -
SPL set ID
f60da70f-2f9e-421d-a277-95b1edb57a71 -
UNII
60158CV180 -
RxCUI
603566
What the source publishes
- Labeler
- Sagent Pharmaceuticals
- Active ingredients
- Nelarabine
- Form
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Nelarabine",
"splId": "c956537f-71c0-44bc-a2e2-ab2adaa4f756",
"labels": [
{
"setId": "f60da70f-2f9e-421d-a277-95b1edb57a71",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f60da70f-2f9e-421d-a277-95b1edb57a71",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f60da70f-2f9e-421d-a277-95b1edb57a71"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Sagent Pharmaceuticals",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL in 1 CARTON (25021-259-50) / 50 mL in 1 VIAL",
"package_ndc": "25021-259-50",
"identifierStatus": "well-formed",
"marketing_start_date": "20240801"
},
{
"sample": false,
"description": "6 VIAL in 1 CARTON (25021-259-51) / 50 mL in 1 VIAL",
"package_ndc": "25021-259-51",
"identifierStatus": "well-formed",
"marketing_start_date": "20240801"
}
],
"productId": "25021-259_c956537f-71c0-44bc-a2e2-ab2adaa4f756",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "25021-259",
"deaSchedule": null,
"genericName": "Nelarabine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "NELARABINE",
"strength": "5 mg/mL"
}
],
"applicationNumber": "ANDA212605",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240801",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000233",
"N0000175595"
],
"unii": [
"60158CV180"
],
"rxcui": [
"603566"
],
"spl_set_id": [
"f60da70f-2f9e-421d-a277-95b1edb57a71"
],
"pharm_class_epc": [
"Nucleoside Metabolic Inhibitor [EPC]"
],
"pharm_class_moa": [
"Nucleic Acid Synthesis Inhibitors [MoA]"
],
"manufacturer_name": [
"Sagent Pharmaceuticals"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:25021-259_c956537f-71c0-44bc-a2e2-ab2adaa4f756"